Bank of Montreal’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
MP
CB
ACM
Bank of Montreal's TCRT Position: Q1 2024 in Review
Bank of Montreal sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 134 shares — an estimated $1.54K sold.
Bank of Montreal first reported a position in TCRT in Q2 2014 and held it in 32 quarters. The position peaked at $1.36M in Q1 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Bank of Montreal reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- Bank of Montreal sold 134 Alaunos Therapeutics shares in Q1 2024, an estimated $1.54K.
- Bank of Montreal first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 32 quarters.
- Bank of Montreal's Alaunos Therapeutics position peaked at $1.36M in Q1 2017.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.